Lead Drug Faces Uncertain FDA Path After Phase 3 Miss
Source: Streetwise Reports (11/13/2025)
aTyr Pharma Inc. (ATYR:NASDAQ) is seeking regulatory clarity following mixed Phase 3 results for its lead candidate efzofitimod in pulmonary sarcoidosis. The company expects feedback from the FDA in the first quarter of 2026 to help determine a potential path forward.
read more >
Explorer Triples Ontario Gold System After Breakthrough 2025 Drilling
Source: Streetwise Reports (11/13/2025)
Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB; FSE: X7W) tripled the strike length of the Elora Gold System to over 800 meters during its 2025 drill program. The company also reported new gold-bearing structures and key intercepts across multiple zones at Gold Rock Camp.
read more >
Silver Co. Extends High-Grade Gold Deposit in Golden Triangle
Source: Streetwise Reports (11/13/2025)
Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) announces drilling results that expand the high-grade gold zone within the Homestake Silver deposit, 26.74 grams per tonne gold (g/t Au) over 14.75 meters, including 122 g/t Au over 2.85 meters.
read more >
Nevada Drill Campaign Hits High Grade Gold in New Target Area
Source: Streetwise Reports (11/13/2025)
Westward Gold Inc. (WG:CSE; WGLIF:OTC; IM50:FSE) has intersected a newly identified Carlin-type gold zone at the Campfire Target Complex, including 3.1 meters of 2.50 g/t gold. The results are part of the company's expanded 2025 drill program at the Toiyabe Hills Project in Nevada.
read more >
Explorer Finds Hidden Gold Corridor in Nevada's Canyon Depths
Source: Streetwise Reports (11/12/2025)
Getchell Gold Corp. (GTCH:CSE; GGLDF:OTCQB) confirmed the discovery of thick, high-grade gold zones at its Fondaway Canyon project in Nevada. The results connected two major mineralized areas, revealing strong continuity across a previously undrilled corridor.
read more >